HomeInsightsStock Comparison

Influx Healthtech Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Influx Healthtech Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 05, 2025

Key Highlights

  • The Latest Trading Price of Influx Healthtech Ltd is ₹ 131.35 as of 04 Jul 15:30.
  • The P/E Ratio of Influx Healthtech Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 14.4 on March 2020 to 46.3 on March 2024 . This represents a CAGR of 26.31% over 5 years.
  • The Market Cap of Influx Healthtech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 3928 crore on March 2020 to ₹ 25598 crore on March 2024 . This represents a CAGR of 45.48% over 5 years.
  • The revenue of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 963.96 crore as compare to the Dec '24 revenue of ₹ 971.49 crore. This represent the decline of -0.78%.
  • The ebitda of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 240.92 crore as compare to the Dec '24 ebitda of ₹ 262.51 crore. This represent the decline of -8.22%.
  • The net profit of Influx Healthtech Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 142.32 crore to ₹ 145.69 crore over 8 quarters. This represents a CAGR of 1.18% .
  • The Dividend Payout of Influx Healthtech Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 31.71 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Influx Healthtech Ltd

  • Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre.
  • Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai. Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc.

About J B Chemicals & Pharmaceuticals Ltd

  • J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
  • The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
  • The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
  • The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
  • Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

Influx Healthtech Ltd News Hub

News

NSE SME Influx Healthtech makes a strong debut

The scrip was listed at Rs 132.50, a premium of 38.02% compared with the initial public of...

Read more

25 Jun 2025 11:42

J B Chemicals & Pharmaceuticals Ltd News Hub

News

J B Chemicals & Pharmaceuticals Ltd leads losers in 'A' group

Jyoti CNC Automation Ltd, Karnataka Bank Ltd, Narayana Hrudayalaya Ltd and Home First Fina...

Read more

30 Jun 2025 15:00

News

J B Chemicals & Pharmaceuticals receives USFDA approval for Amitriptyline Hydrochloride Tablets

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Adm...

Read more

26 Jun 2025 18:33

News

JB Chemicals receives USFDA approval for Amitriptyline Hydrochloride tablets

The approved dosages'10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg'are indicated for the ...

Read more

25 Jun 2025 12:22

News

J B Chemicals receives USFDA approval for Amitriptyline Hydrochloride Tablets

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Adm...

Read more

24 Jun 2025 18:31

News

J B Chemicals & Pharmaceuticals allots 85,390 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 85,390 equity shares under ESOS. Consequently...

Read more

11 Jun 2025 18:10

News

J B Chemicals & Pharmaceuticals allots 1.12 lakh equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 112,990 fully paid up equity shares of Re. 1/...

Read more

05 Jun 2025 12:59

SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for J B Chemicals & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Influx Healthtech Ltd and J B Chemicals & Pharmaceuticals Ltd

Which company has a larger market capitalization, Influx Healthtech Ltd or J B Chemicals & Pharmaceuticals Ltd?

Market cap of Influx Healthtech Ltd is 304 Cr while Market cap of J B Chemicals & Pharmaceuticals Ltd is 25,547 Cr

What are the key factors driving the stock performance of Influx Healthtech Ltd and J B Chemicals & Pharmaceuticals Ltd?

The stock performance of Influx Healthtech Ltd and J B Chemicals & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Influx Healthtech Ltd and J B Chemicals & Pharmaceuticals Ltd?

As of July 5, 2025, the Influx Healthtech Ltd stock price is INR ₹131.35. On the other hand, J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹1637.05.

How do dividend payouts of Influx Healthtech Ltd and J B Chemicals & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Influx Healthtech Ltd and J B Chemicals & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions